Computer Simulations of Silicide-Tetrahedrite Thermoelectric Generators.

With global warming and rising energy demands, it is important now than ever to transit to renewable energy systems. Thermoelectric (TE) devices can present a feasible alternative to generate clean energy from waste heat. However, to become attractive for large-scale applications, such devices must be cheap, efficient, and based on ecofriendly materials.

Large granular lymphocyte leukaemia study at the University Hospital of Donostia.

Introduction: Large granular lymphocyte (LGL) leukaemia is considered a mature T-cell or natural killer (NK) cell neoplasm, characterised by a clonal proliferation of LGL.

Aims: To analyse the characteristics and to establish (if possible) the prognostic parameters of these patients diagnosed in a single centre: University Hospital of Donostia.

Methods: We retrospectively studied data about 308 patients with LGL leukaemia diagnosed in our centre.

Experimental Evidence of the Viability of Thermoelectric Generators to Power Volcanic Monitoring Stations.

Although there is an important lack of commercial thermoelectric applications mainly due to their low efficiency, there exist some cases in which thermoelectric generators are the best option thanks to their well-known advantages, such as reliability, lack of maintenance and scalability. In this sense, the present paper develops a novel application in order to supply power to volcanic monitoring stations, making them completely autonomous. These stations become indispensable in any volcano since they are able to predict eruptions.

Evaluation of the predictive value of the hematopoietic progenitor cell count using an automated hematology analyzer for CD34+ stem cell mobilization and apheresis product yield.

Introduction: We evaluated the value of hematopoietic progenitor cells (HPCs) counted in Sysmex XN analyzers to predict the mobilization and collection of CD34+ cells in apheresis for stem cell transplantation.

Methods: Eighty patients who underwent stem cell transplantation were enrolled (50 autologous and 30 allogeneic). In the autologous group, patients were considered poor mobilizers when the CD34+ count was <10 × 10 /L or <20 × 10 /L in patients with multiple myeloma who were going to undergo two transplants.